SVG
FasterCures
Featured
Report
Community-Based Infrastructure for Inclusive Research: Democratizing Access to Research
FasterCures’ work, spurred by the COVID-19 pandemic, identified numerous challenges in both the publicly and privately funded...
Read
Report
Featured
Report
Community-Based Infrastructure for Inclusive Research: Democratizing Access to Research
FasterCures’ work, spurred by the COVID-19 pandemic, identified numerous challenges in both the publicly and privately funded...
Read
Report
FasterCures is working to build a system that is effective, efficient, and driven by a clear vision: patient needs above all else. We believe that transformative and life-saving science should be fully realized and deliver better treatments to the people who need them.
SVG
FasterCures
Practice Areas
Today's biomedical research system is often siloed, bureaucratic, and too slow to meet the needs of patients across the globe. We accelerate biomedical science and innovation to remove unnecessary barriers so that lifesaving and life-enhancing treatments can reach those who need them as rapidly and as safely as possible.
Accelerating Innovation
Removing barriers to innovations that hold great promise for patients, and facilitating dialogue on the path forward for new technologies.
Advancing Health Around the World
Promoting investments and policies to build early warning systems as a core component of surveillance strategies to identify threats of the pandemic potential.
Engaging Patients in Research and Health
Strengthening the ability of patient foundations, non-profit organizations, and patients to engage with the R&D process from beginning to end in full partnership.
Improving the R&D Environment
Preserving the lessons learned from COVID-19, ensuring the engagement of diverse communities in research, and supporting efforts to speed clinical trials and build inclusive research infrastructure.
FasterCures
Most Recent Content
Community-Based Infrastructure for Inclusive Research: Democratizing Access to Research
FasterCures’ work, spurred by the COVID-19 pandemic, identified numerous challenges in both the publicly and privately funded research ecosystems that make it difficult for established players to sustain and scale efforts to move research...Read Report
Prescription for Biomedical Innovation: Recommendations for the New Administration
FasterCures has long been at the forefront of shaping the national focus on biomedical innovation, with a singular goal of saving lives by accelerating scientific advances for all patients. FasterCures has been instrumental in advocating...Read Report
Defining and Demonstrating the Value of Patient Engagement in Medtech Research and Product Development
In 2022, FasterCures published a report titled The Current Landscape of the Science of Patient Input, which examined the progress of patient engagement (PE) in biomedical research and identified ways to overcome ongoing challenges. Building...Read Report
Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies
Dr. Richard Pazdur Director Oncology Center of Excellence US Food and Drug Administration Beltsville, MD 20705 Dr. Michelle Tarver Acting Director Center for Devices and Radiological Health US Food and Drug Administration Silver Spring, MD...Read LetterComment Letter: Action Plans to Improve Diversity in Clinical Studies
Image
Esther Krofah
Executive Vice President, Milken Institute HealthEsther Krofah is the executive vice president of Milken Institute Health, leading FasterCures, Public Health, the Future of Aging, and Feeding Change. She has extensive experience managing efforts to unite diverse stakeholders to solve critical issues and achieve shared goals that improve patients’ lives.
Milken Institute Leaders Share Expertise, Highlight Key Initiatives at United Nations General Assembly Week
September 23, 2024 (New York, NY) — Leaders of the Milken Institute, a global nonpartisan think tank, are on the ground participating in and around the 79th Session of the United Nations General Assembly (UNGA).Read ArticleImage
Paul Guequierre
Director, Strategic CommunicationsPaul Guequierre is the director of strategic communications. In this role, he works to increase the profile of Milken Institute in the media, raise the visibility of issues important to the organization and its stakeholders, and expand the Institute's digital presence.Optimizing the Food and Drug Administration’s Use of and Processes for Advisory Committees
The FasterCures team at the Milken Institute is honored to provide its response to the Request for Comments on Optimizing the Food and Drug Administration’s Use of and Processes for Advisory Committees; Public Meeting; Request for Comments...Read LetterImageEsther Krofah
Executive Vice President, Milken Institute HealthEsther Krofah is the executive vice president of Milken Institute Health, leading FasterCures, Public Health, the Future of Aging, and Feeding Change. She has extensive experience managing efforts to unite diverse stakeholders to solve critical issues and achieve shared goals that improve patients’ lives.Request for Information on Next-Generation Cures Bill
The Honorable Diana DeGette US House of Representatives Washington, DC 20515 The Honorable Larry Bucshon, MD US House of Representatives Washington, DC 20515 Re: Request for Information on Next-Generation Cures Bill Dear Representatives...Read LetterImageEsther Krofah
Executive Vice President, Milken Institute HealthEsther Krofah is the executive vice president of Milken Institute Health, leading FasterCures, Public Health, the Future of Aging, and Feeding Change. She has extensive experience managing efforts to unite diverse stakeholders to solve critical issues and achieve shared goals that improve patients’ lives.
Patients Most In Need Face Obstacles to Participating in Life-Saving Clinical Trials According to a New Milken Institute Report
June 24, 2024 (Washington, DC)— Clinical trials can provide the possibility to obtain novel treatments for conditions and diseases that are not yet commercially available. Yet, these lifesaving treatments are often difficult or impossible...Read ArticleImagePaul Guequierre
Director, Strategic CommunicationsPaul Guequierre is the director of strategic communications. In this role, he works to increase the profile of Milken Institute in the media, raise the visibility of issues important to the organization and its stakeholders, and expand the Institute's digital presence.
Get the latest from FasterCures
FasterCures
Our Team
Image
Ayodola Anise
Senior Director, Operations, MI Health
Image
June Cha
Policy Director, FasterCures, Milken Institute Health
Image
Ugonnah Chilmaza
Senior Associate, FasterCures, Milken Institute Health
Image
Sung Hee Choe
Managing Director, FasterCures, Milken Institute Health
Image
Erin Cieslewski
Associate, FasterCures
Image
Hadly Clark
Director, FasterCures, Milken Institute Health
Image
Brenda Huneycutt
Senior Director, International, MI Health
Image
Esther Krofah
Executive Vice President, Milken Institute Health
Image
Raymond Puerini
Director, FasterCures, Milken Institute Health
Image
Kristin Schneeman
Senior Director, FasterCures, Milken Institute Health
Image
Erika Stratmann
Director, Communications, MI Health
Image
Aneri Suthar
Senior Associate, FasterCures, Milken Institute Health
Image
Belle Tabas
Senior Associate, FasterCures, Milken Institute Health
Image
Amanda Wagner Gee
Associate Director, FasterCures, Milken Institute Health
Image
Mark Williams
Associate Director, FasterCures, Milken Institute Health
FasterCures
Leaders
FasterCures Advisory Board
The FasterCures Advisory Board includes policy experts, public health advocates, and leaders in biomedical innovation. Together with the FasterCures staff, they identify areas of opportunity across the healthcare and biomedical research...
Learn moreFasterCures Business Council
The FasterCures Business Council brings together leaders committed to FasterCures’ mission to speed treatments and cures. Given the leadership and expertise that they have demonstrated across the health landscape, members have the...
Learn moreChangemakers
What is the power of philanthropy to disrupt the biomedical innovation ecosystem? That is a question that will be tested by the members of our new advisory group, which brings together the chief executives of 22 leading nonprofit, patient...
Learn more